Trandolapril

ABBOTT LABORATORIES Abbott Park US

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R0-CEP 2019-137 - Rev 01

Status

Valid

Type

Chemical

Issue Date

2022-09-08

End Date

Substance Number

2245

01

ABBOTT LABORATORIES Abbott Park US

U.S.A

BioFlorida Conference

Not Confirmed

ABBOTT LABORATORIES Abbott Park US

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Trandolapril

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R1-CEP 2009-182 - Rev 01

Status

Valid

Type

Chemical

Issue Date

2020-03-13

End Date

Substance Number

2245

02

ABBOTT LABORATORIES Abbott Park US

U.S.A

BioFlorida Conference

Not Confirmed

VITALIFE LABORATORIES Mumbai IN

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Trandolapril

Product Web Link

Corporate PDF

Certificate Number

R1-CEP 2007-287 - Rev 02

Status

Valid

Type

Chemical

Issue Date

2020-02-05

End Date

Substance Number

2245

03

VITALIFE LABORATORIES Mumbai IN

India

BioFlorida Conference

Not Confirmed

APITORIA PHARMA PRIVATE LIMITED Hyd...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Trandolapril

Portfolio PDF

Product Web Link

Certificate Number

CEP 2007-184 - Rev 06

Status

Valid

Type

Chemical

Issue Date

2023-11-16

End Date

Substance Number

2245

04

APITORIA PHARMA PRIVATE LIMITED Hyd...

India

BioFlorida Conference

Not Confirmed

LUPIN LIMITED Mumbai IN

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Trandolapril

Product Web Link

Corporate PDF

Certificate Number

R1-CEP 2009-099 - Rev 01

Status

Withdrawn by Holder

Type

Chemical

Issue Date

2019-06-25

End Date

2023-02-13

Substance Number

2245

05

LUPIN LIMITED Mumbai IN

India

BioFlorida Conference

Not Confirmed

ROLABO OUTSOURCING, S.L. Zaragoza E...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Spain

Virtual Booth

Digital Content

Trandolapril

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R1-CEP 2009-251 - Rev 01

Status

Valid

Type

Chemical

Issue Date

2019-12-16

End Date

Substance Number

2245

06

ROLABO OUTSOURCING, S.L. Zaragoza E...

Spain

BioFlorida Conference

Not Confirmed

Trandolapril

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

8 USDMF

6 CEP/COS

3 JDMF

3 EU WC

4 NDC API

6 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers

33 FDA Orange Book

8 Europe

29 Canada

24 Australia

8 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

5 SPI Pharma

2 Seqens

4 DKSH

2 Jai Radhe Sales

5 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

13 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 ACG Worldwide

3 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Finar

7 Gangwal Chemicals

6 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 NEWEDGE Overseas

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders

47 Coating Systems & Additives

33 Direct Compression

29 Controlled & Modified Release

24 Disintegrants & Superdisintegrants

20 Granulation

20 Thickeners and Stabilizers

TABLET;ORAL - 1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons